0001123292-17-001103.txt : 20170607 0001123292-17-001103.hdr.sgml : 20170607 20170607160244 ACCESSION NUMBER: 0001123292-17-001103 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20170605 FILED AS OF DATE: 20170607 DATE AS OF CHANGE: 20170607 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Recro Pharma, Inc. CENTRAL INDEX KEY: 0001588972 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 261523233 STATE OF INCORPORATION: PA FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 490 LAPP ROAD CITY: MALVERN STATE: PA ZIP: 19355 BUSINESS PHONE: (484) 395-2400 MAIL ADDRESS: STREET 1: 490 LAPP ROAD CITY: MALVERN STATE: PA ZIP: 19355 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Lake Ryan David CENTRAL INDEX KEY: 0001450325 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36329 FILM NUMBER: 17897290 MAIL ADDRESS: STREET 1: KENSEY NASH CORPORATION STREET 2: 735 PENNSYLVANIA DRIVE CITY: EXTON STATE: PA ZIP: 19341 4 1 edgar.xml PRIMARY DOCUMENT X0306 4 2017-06-05 0001588972 Recro Pharma, Inc. REPH 0001450325 Lake Ryan David C/O RECRO PHARMA, INC. 490 LAPP ROAD MALVERN PA 19355 0 1 0 0 Senior VP, Finance & CAO Employee Stock Option (right to buy) 7.58 2017-06-05 4 A 0 65000 0 A 2027-06-05 Common Stock 65000 65000 D Restricted Stock Units 2017-06-05 4 A 0 10000 0 A Common Stock 10000 10000 D The stock option vests in equal monthly installments over 48 months, beginning on the date that is one month from the date of grant, subject to continued employment with the Company. The stock option is an inducement grant under NASDAQ listing rule 5635(c)(4). Each restricted stock unit represents a contingent right to receive one share of the Company's common stock. The restricted stock units vest in four equal annual installments beginning June 5, 2018. Vested shares will be delivered to the reporting person within 30 days following each respective vesting date. The restricted stock unit award is an inducement grant under NASDAQ listing rule 5635(c)(4). /s/ Ryan D. Lake 2017-06-07